| Literature DB >> 32840571 |
Stefano Busani1, Andrea Bedini2, Emanuela Biagioni1, Lucia Serio1, Roberto Tonelli3, Marianna Meschiari2, Erica Franceschini2, Giovanni Guaraldi2, Andrea Cossarizza4, Enrico Clini3, Antonino Maiorana5, William Gennari6, Nicola De Maria7, Mario Luppi8, Cristina Mussini2, Massimo Girardis1.
Abstract
We report two fatal cases of acute liver failure secondary to herpes simplex virus 1 infection in COVID-19 patients, following tocilizumab and corticosteroid therapy. Screening for and prompt recognition of herpes simplex virus 1 reactivation in these patients, undergoing immunomodulatory treatment, may have potentially relevant clinical consequences.Entities:
Mesh:
Year: 2021 PMID: 32840571 PMCID: PMC7499514 DOI: 10.1093/cid/ciaa1246
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079